Tenofovir versus entecavir in the treatment of chronic hepatitis B with severe acute exacerbation

被引：0
|
作者：
Hung, Chao-Hung [1 ]
Chen, Chien-Hung [1 ]
Lu, Sheng-Nan [1 ]
Hu, Tsung-Hui [1 ]
Wang, Jing-Houng [1 ]
Lee, Chuan-Mo [1 ]
机构：
[1] Kaohsiung Chang Gung Mem Hosp, Dept Internal Med, Div Hepatogastroenterol, Kaohsiung, Taiwan
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1906
引用
收藏
页码：1118A / 1118A
页数：1
相关论文
共 50 条
  • [21] Tenofovir, entecariv and lamivudine in patients with severe acute exacerbation and hepatic decompensation of chronic hepatitis B
    Park, J. G.
    Lee, Y. R.
    Park, S. Y.
    Lee, H. J.
    Tak, W. Y.
    Kweon, Y. O.
    Jang, S. Y.
    Keun, H.
    Kang, M. K.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S477 - S477
  • [22] The pros and cons of lamivudine vs. entecavir in decompensated or severe acute exacerbation of chronic hepatitis B
    Shouval, Daniel
    JOURNAL OF HEPATOLOGY, 2014, 60 (06) : 1108 - 1109
  • [23] Entecavir vs. lamivudine in chronic hepatitis B patients with severe acute exacerbation and hepatic decompensation
    Chen, Chien-Hung
    Lin, Chih-Lang
    Hu, Tsung-Hui
    Hung, Chao-Hung
    Tseng, Po-Lin
    Wang, Jing-Houng
    Chang, Juan-Yu
    Lu, Sheng-Nan
    Chien, Rong-Nan
    Lee, Chuan-Mo
    JOURNAL OF HEPATOLOGY, 2014, 60 (06) : 1127 - 1134
  • [24] ENTECAVIR TREATMENT IN A CASE OF SEVERE ACUTE HEPATITIS B
    Amoruso, C.
    Fedeli, S. F.
    Farallo, M.
    Celano, R.
    Lampertico, P.
    Vigano, M.
    Agostoni, C. V.
    Nebbia, G.
    DIGESTIVE AND LIVER DISEASE, 2010, 42 : S368 - S369
  • [25] Treatment with lamivudine and entecavir in severe acute hepatitis B
    Streinu-Cercel, A.
    Sandulescu, O.
    Stefan, M.
    Streinu-Cercel, A.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 34 (02) : 166 - 172
  • [26] A Randomized Controlled Trial of Glycyrrhizin Plus Tenofovir vs. Tenofovir in Chronic Hepatitis B with Severe Acute Exacerbation
    Hung, Chao-Hung
    Kee, Kwong-Ming
    Chen, Chih-Hung
    Tseng, Po-lin
    Tsai, Ming-Chao
    Chen, Chien-Hung
    Wang, Jing-Houng
    Chang, Kuo-Chin
    Kuo, Yuan-Hung
    Yen, Yi-Hao
    Hu, Tsung-Hui
    Lu, Sheng-Nan
    CLINICAL AND TRANSLATIONAL GASTROENTEROLOGY, 2017, 8
  • [27] Randomized Controlled Study of Tenofovir versus Lamivudine Followed by Tenofovir in Severe Exacerbation of Hepatitis B
    Lu, Chia-Ming
    Cheng, Jin-Shiung
    Sun, Wei-Chih
    Chen, Wen-Chi
    Tsay, Feng-Woei
    Wang, Huay-Min
    Tsai, Tzung-Jiun
    Kao, Sung-Shuo
    Li, Yun-Da
    Li, Yuan-Rong
    Lin, Huey-Shyan
    Yin, Chun-Hao
    Tsai, Wei-Lun
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (02)
  • [28] Virologic Response and Safety of Tenofovir Versus Entecavir in Treatment-Naive Chronic Hepatitis B Patients
    Yu, Hyung Min
    Kwon, So Young
    Kim, Jiwan
    Chung, Hyun Ah
    Kwon, Se Woong
    Jeong, Taek Gun
    An, Sang Hee
    Jeong, Gyung Won
    Yun, Seon Ung
    Min, Jae Ki
    Kim, Jeong Han
    Choe, Won Hyeok
    SAUDI JOURNAL OF GASTROENTEROLOGY, 2015, 21 (03): : 146 - 151
  • [29] Efficacy and safety of entecavir versus tenofovir treatment in chronic hepatitis B patients: A randomized controlled trial
    Sriprayoon, Tassanee
    Mahidol, Chulabhorn
    Ungtrakul, Teerapat
    Chun-on, Pattra
    Soonklang, Kamonwan
    Pongpun, Wanvisa
    Laohapand, Charlie
    Dechma, Jiraporn
    Pothijaroen, Charinthip
    Auewarakul, Chirayu
    Tanwandee, Tawesak
    HEPATOLOGY RESEARCH, 2017, 47 (03) : E161 - E168
  • [30] Efficacy and Safety of Entecavir Versus Tenofovir Treatment in Chronic Hepatitis B Patients: A Randomized Controlled Trial
    Sriprayoon, Tassanee
    Lueangarun, Saoraya
    Suwanwela, Charas
    Pittayapoom-Pattaranutaporn
    Tanwandee, Tawesak
    GASTROENTEROLOGY, 2012, 142 (05) : S695 - S695
12345